Anti-frostbite effects of Prunus tomentosa thunb total flavone

European Journal of Inflammation

Volumn 9, Issue 1, 2011, Pages 65-71

  Zhang, Cheng Yi ^a,b   Shao, S H ^a   Chen, X ^b   Shi, Y L ^b  

^a JIANGSU UNIVERSITY   (China)

^b BEIHUA UNIVERSITY   (China)

Author keywords

Chinese traditional medicine; IL 1 ; Inflammation and immunoregulation; MMP 9; PTTTF

Indexed keywords

GELATINASE B; INTERLEUKIN 1BETA; NITROGEN; PRUNUS EXTRACT; PRUNUS TOMENTOSA THUNB TOTAL FLAVONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASCITES; COLD INJURY; CONTROLLED STUDY; DRUG EFFICACY; EAR; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PRUNUS; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 80053983613     PISSN: 1721727X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1721727X1100900110     Document Type: Article

References (14)

1. Huiying Z, Zhimou X, Zhengyu Z, et al. The establishment of rabbit frostbite model. Shanghai Laboratory Animal Science 2003; 23:51-52.
2. Iana Bantim Felício C, Daniel Italo Maia S, Geanne Matos de Andrade C, et al. Topically Applied Diterpenoids from Egletes viscosa (Asteraceae) Attenuate the Dermal Inflammation in Mouse Ear Induced by Tetradecanoylphorbol 13-Acetate- and Oxazolone. Biol Pharm Bull 2008; 31:1511-16.
3. Andre LM, John VS, Sushma B, et al. p53 mutation in adenocarcinoma arising in retrorectal cyst hamartoma (Tailgut Cyst): Report of 2 Cases - an immunohistochemistry/immunoperoxidase study. Arch Pathol Lab Med 2001; 125:1361-64.
4. Sands KE. Epidemiology of sepsis syndrome in 8 academic medical centers. AMA 1997; 278:234-40. (Pubitemid 27339591)
5. Angus DC. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-10. (Pubitemid 32641789)
6. Martin GS. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54. (Pubitemid 36437931)
7. Gibson RM, Rothwell NJ, Le Feuvre RA. CNS injury: the role of the cytokine IL-1. Vet J 2004; 168:230-37. (Pubitemid 39406745)
8. Kane D, Jensen LE, Grehan S, Whitehead AS, Bresnihan B, Fitzgerald O. Quantitation of metalloproteinase gene expression in rheumatoid and psoriatic arthritis synovial tissue distal and proximal to the cartilage-pan-nus junction. J Rheumatol 2004; 31:1274-80. (Pubitemid 38879188)
9. Foxwell BM, Bondeson J, Brennan F, Feldmann M. Adenoviral transgene delivery provides an approach to identifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFkappaB in rumour necrosis factor production. Ann Rheum Dis 2000; 59:154-59.
10. Koenders MI, Kolls JK, Oppers-Walgreen B, et al. Interleukin-17 receptor deficiency results in impaired synovial expression of interleukin-1 and matrix metalloproteinases 3,9, and 13 and prevents cartilage destruction during chronic reactivated streptococcal cell wall-induced arthritis. Arthritis Rheum 2005; 52:3239-47. (Pubitemid 41447107)
11. Gayle G, Vaday R, Hershkoviz, et al. Fibronectin bound TNF-α stimulates monocyte matrix metalloproteinase-9 expression and regulate Chemotaxis. J Leuko Bio 2000; 68:737-47.
12. Lobmunn R, Ambrosch A, Schultz G, et al. Expression of matrixmetalloprotienases and their inhibitors in the wounds of diabetic and non-diabetic Patients. Diabetologia 2002; 45:1011-16. (Pubitemid 34762196)
13. Fredeinok J. Martrix metalloproteinase and their inhibitor in connective tissue remodeling. FASEB J 1991; 5:2145-54.
14. Yoshihara Y, Nakamara H, Obatak, et al. Martrix meatlloproeinase and tissue inhibitor of metalloprot einase in synovial fluids from patients with RA or osteoarthritis. Ann Rheum Dis 2000; 59:455-61. (Pubitemid 30395603)